{"doi":"10.1038/s41591-021-01285-x","title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","abstract":null,"journal":"Nature Medicine","year":2021,"id":21649,"datarank":17.9606895878894,"base_score":7.149916836132109,"endowment":7.149916836132109,"self_citation_contribution":1.0724875254198165,"citation_network_contribution":16.888202062469585,"self_endowment_contribution":1.0724875254198165,"citer_contribution":16.888202062469585,"corpus_percentile":null,"corpus_rank":null,"citation_count":1273,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":16,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":138607,"name":"Frances Ayres","orcid":null,"position":1,"is_corresponding":false},{"id":138608,"name":"Tandile Hermanus","orcid":null,"position":2,"is_corresponding":false},{"id":138609,"name":"Mashudu Madzivhandila","orcid":null,"position":3,"is_corresponding":false},{"id":138610,"name":"Prudence Kgagudi","orcid":null,"position":4,"is_corresponding":false},{"id":138611,"name":"Brent Oosthuysen","orcid":null,"position":5,"is_corresponding":false},{"id":138612,"name":"Bronwen E. Lambson","orcid":null,"position":6,"is_corresponding":false},{"id":138613,"name":"Tulio de Oliveira","orcid":null,"position":7,"is_corresponding":false},{"id":138614,"name":"Marion Vermeulen","orcid":null,"position":8,"is_corresponding":false},{"id":138615,"name":"Karin van der Berg","orcid":"0000-0001-9805-8013","position":9,"is_corresponding":false},{"id":138616,"name":"Theresa Rossouw","orcid":null,"position":10,"is_corresponding":false},{"id":138617,"name":"Michael Boswell","orcid":"0000-0003-2152-1617","position":11,"is_corresponding":false},{"id":138618,"name":"Veronica Ueckermann","orcid":null,"position":12,"is_corresponding":false},{"id":138619,"name":"Susan Meiring","orcid":"0000-0003-4508-5469","position":13,"is_corresponding":false},{"id":138620,"name":"Anne von Gottberg","orcid":null,"position":14,"is_corresponding":false},{"id":138622,"name":"Cheryl Cohen","orcid":null,"position":15,"is_corresponding":false},{"id":36867,"name":"Lynn Morris","orcid":"0000-0003-3961-7828","position":16,"is_corresponding":false},{"id":138626,"name":"Jinal N. Bhiman","orcid":"0000-0001-6354-4003","position":17,"is_corresponding":false},{"id":138629,"name":"Penny L. Moore","orcid":"0000-0001-8719-4028","position":18,"is_corresponding":false},{"id":138606,"name":"Constantinos Kurt Wibmer","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":7.149916836132109,"endowment":7.149916836132109,"datacite_reuse_total":16,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33654292","pmcid":null,"openalex_id":"https://openalex.org/W3133794453","authors":[],"funders":[{"funder_name":"FIC NIH HHS","grant_id":"R21 TW011454","title":null},{"funder_name":"CDC HHS","grant_id":"5 U01IP001048-05-00","title":null},{"funder_name":"FIC NIH HHS","grant_id":"D43 TW010345","title":null},{"funder_name":"National Institutes of Health","grant_id":"1U01IP001048-01","title":"Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09"},{"funder_name":"National Institutes of Health","grant_id":"5D43TW010345-08","title":"Blood Research and EnhAnced Training against HIV in South Africa (BREATH-SA)"},{"funder_name":"National Institutes of Health","grant_id":"5R21TW011454-02","title":"Rational structure-guided design of broadly reactive next-generation therapeutics to treat non-communicable snakebite in Africa"},{"funder_name":"National Institutes of Health","grant_id":"5U01IP001048-05","title":"IP16-003, Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09"},{"funder_name":"Wellcome Trust","grant_id":"221003","title":"Characterization of SARS-CoV-2 transmission dynamics, clinical features and disease impact in South Africa, a setting with high HIV prevalence"},{"funder_name":"National Institutes of Health","grant_id":"5D43TW010345-05","title":"Research training in HIV-related transfusion medicine and hematology in South Africa"}],"total_grants":9,"fwci":80.3116,"citation_percentile":0.99964161,"influential_citations":57,"citation_trend":[{"year":2020,"count":6},{"year":2021,"count":745},{"year":2022,"count":330},{"year":2023,"count":100},{"year":2024,"count":56},{"year":2025,"count":30},{"year":2026,"count":6}],"oa_status":"bronze","license":"Springer Nature TDM","oa_locations":[{"url":"https://www.nature.com/articles/s41591-021-01285-x.pdf","host_type":"journal"},{"url":"https://www.nature.com/articles/s41591-021-01285-x.pdf","host_type":"HYBRID"},{"url":"https://www.nature.com/articles/s41591-021-01285-x.pdf","host_type":"publisher"},{"url":"https://www.nature.com/articles/s41591-021-01285-x","host_type":"publisher"},{"url":"https://doi.org/10.1038/s41591-021-01285-x","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33654292","host_type":"repository"},{"url":"http://hdl.handle.net/2263/79329","host_type":"repository"},{"url":"https://doi.org/10.1101/2021.01.18.427166","host_type":""},{"url":"https://pubmed.ncbi.nlm.nih.gov/33501446","host_type":""},{"url":"http://dx.doi.org/10.1101/2021.01.18.427166","host_type":""},{"url":"https://dx.doi.org/10.1038/s41591-021-01285-x","host_type":""},{"url":"https://dx.doi.org/10.1101/2021.01.18.427166","host_type":""},{"url":"https://doi.org/https://doi.org/10.1038/s41591-021-01285-x","host_type":""}],"fields_of_study":["SARS-CoV-2 and COVID-19 Research","Animal Virus Infections Studies","SARS-CoV-2 detection and testing","Biology","Medicine","Antibodies, Viral","Blood Donors","COVID-19","COVID-19 Vaccines","Humans","Immune Evasion","Neutralization Tests","SARS-CoV-2","Spike Glycoprotein, Coronavirus"],"mesh_terms":["COVID-19","SARS-CoV-2","COVID-19 Vaccines","Antibodies, Viral","Blood Donors","Humans","Neutralization Tests","Immune Evasion","Spike Glycoprotein, Coronavirus"],"keywords":["Neutralization","Convalescent plasma","Spike Protein","Virology","Monoclonal antibody","Antibody","Lineage (genetic)","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Coronavirus disease 2019 (COVID-19)","Recombinant DNA","Coronavirus","Biology","Spike (software development)","2019-20 coronavirus outbreak","Gene","Genetics","Medicine","COVID-19 Vaccines","SARS-CoV-2","COVID-19 pandemic","COVID-19","Blood Donors","Antibodies, Viral","Article","Neutralization Tests","Spike Glycoprotein, Coronavirus","Infectious diseases","Humans","Immune Evasion"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.14767272.v1","title":"Additional file 1 of Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14767272","title":"Additional file 1 of Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16388173.v1","title":"Additional file 1 of An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16388173","title":"Additional file 1 of An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16544100.v1","title":"Additional file 1 of The association between mechanical ventilator compatible bed occupancy and mortality risk in intensive care patients with COVID-19: a national retrospective cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16544100","title":"Additional file 1 of The association between mechanical ventilator compatible bed occupancy and mortality risk in intensive care patients with COVID-19: a national retrospective cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16544166.v1","title":"Additional file 1 of Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16544166","title":"Additional file 1 of Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16544169.v1","title":"Additional file 2 of Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.16544169","title":"Additional file 2 of Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.17047290.v1","title":"Additional file 1 of SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.17047290","title":"Additional file 1 of SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19094140.v1","title":"Additional file 1 of Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19094140","title":"Additional file 1 of Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25239391.v1","title":"Additional file 1 of Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusion","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25239391","title":"Additional file 1 of Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusion","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-06T16:27:37.125327Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}